ENTITY

Vitae Pharmaceuticals (VTAE US)

Health Care • United States

Vitae Pharmaceuticals, Inc. offers clinical-stage biopharmaceutical products. The Company develops small molecule compounds that address medical needs such as chronic kidney disease, diabetes, atherosclerosis, and alzheimer's diseases. Vitae Pharmaceuticals operates in the United States.

Refresh

Focused

No publications yet

There aren’t any buy-side reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00